260 Impact of BRCA &amp; PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)

O Le Saux; AM Savoye; MA Mouret-Reynier; C Schiffler; O Derbel; T Isabelle; E Kalbacher; S Gouerant; A Martinez; C Cornila; M Martinez; L Bengrine Lefevre; F Priou; N Cloarec; L Venat-Bouvet; A Angelergues; D Berton; O Collard; E Coquan; I Ray-Coquard

doi:10.1136/ijgc-2021-ESGO.369

Article info

Ovarian cancer

260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)

Free

Authors

O Le Saux Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France PubMed articles Google scholar articles
AM Savoye Institut Jean Godinot, Reims, France PubMed articles Google scholar articles
MA Mouret-Reynier Centre Jean Perrin, Department of Medical Oncology, Clermont-Ferrand, France PubMed articles Google scholar articles
C Schiffler Centre Léon Bérard, Direction de la Recherche clinique et de l’Innovation , Lyon, France PubMed articles Google scholar articles
O Derbel Institut de Cancérologie, Hôpital Privé Jean Mermoz, Lyon, France PubMed articles Google scholar articles
T Isabelle Centre Léon Bérard, Lyon, France PubMed articles Google scholar articles
E Kalbacher CHRU Jean Minjoz, Besançon, France PubMed articles Google scholar articles
S Gouerant Centre Henri-Becquerel, Department of Medical Oncology, Rouen , France PubMed articles Google scholar articles
A Martinez Institut Claudius Régaud IUCT-O, Toulouse, France PubMed articles Google scholar articles
C Cornila Centre Hospitalier Régional d’Orléans, Orléans, France PubMed articles Google scholar articles
M Martinez Clinique Pasteur, Toulouse, France PubMed articles Google scholar articles
L Bengrine Lefevre Centre Georges-François Leclerc, Dijon, France PubMed articles Google scholar articles
F Priou CHD Vendée – Hôpital Les Oudairies, La Roche-Sur-Yon, France PubMed articles Google scholar articles
N Cloarec Centre Hospitalier Henri Duffaut, Avignon, France PubMed articles Google scholar articles
L Venat-Bouvet Centre Hospitalier Universitaire Dupuytren, Limoges, France PubMed articles Google scholar articles
A Angelergues Groupe Hospitalier Diaconesses Croix Saint-Simon, Department of Medical Oncology, Paris , France PubMed articles Google scholar articles
D Berton ICO – Centre René Gauducheau, Saint-Herblain, France PubMed articles Google scholar articles
O Collard Institut de Cancérologie de la Loire – Lucien Neuwirth , Department of Medical Oncology, Saint-Priest-en-Jarez, France PubMed articles Google scholar articles
E Coquan Centre François Baclesse, Department of Medical Oncology, Caen, France PubMed articles Google scholar articles
I Ray-Coquard PubMed articles Google scholar articles

Citation

Le Saux O, Savoye A, Mouret-Reynier M, et al

260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO)

International Journal of Gynecologic Cancer 2021;31:A216-A217.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password